Guangzhou LBP Medicine Science & Technology Co., Ltd.

SSE:688393.SS

29.83 (CNY) • At close June 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202420232022202120202019201820172016201320122011
Revenue 470.79497.291507.381438.989375.433355.16306.296260.47241.16142.601107.44687.719
Cost of Revenue 154.255161.872146.7596.94775.96457.94352.17443.20742.74646.27137.42930.766
Gross Profit 316.535335.419360.631342.042299.469297.217254.122217.262198.41596.32970.01756.953
Gross Profit Ratio 0.6720.6740.7110.7790.7980.8370.830.8340.8230.6760.6520.649
Reseach & Development Expenses 40.962.68767.39445.90227.73221.85915.58615.30513.25110.61715.980
General & Administrative Expenses 4.08118.05120.4518.9110.6195.1564.7793.721.20323.86925.01113.229
Selling & Marketing Expenses 105.716181.663185.975179.594153.556161.883141.808122.84112.57231.62614.32714.677
SG&A 109.797263.287206.425198.504164.175167.039146.586126.539133.77555.49539.33827.905
Other Expenses 154.836-12.06855.20630.59111.82120.0470.11-0.5718.2873.9772.3854.447
Operating Expenses 305.533319.104329.025274.997203.729208.944179.434157.3150.02657.21740.39929.246
Operating Income 11.00221.51338.85388.94100.19688.79674.36360.64646.98340.26229.90627.342
Operating Income Ratio 0.0230.0430.0770.2030.2670.250.2430.2330.1950.2820.2780.312
Total Other Income Expenses Net -1.567-4.663-10.062-0.216-0.343-1.5480.11-0.5718.2873.9772.3854.447
Income Before Tax 9.43416.84928.79188.72499.85387.24874.47360.07555.26944.2432.29131.788
Income Before Tax Ratio 0.020.0340.0570.2020.2660.2460.2430.2310.2290.310.3010.362
Income Tax Expense -5.466-4.17-0.53913.44116.23114.44412.05310.3338.415.8364.5574.638
Net Income 21.29140.05729.3379.77684.74673.98961.47248.33946.02938.43127.73427.15
Net Income Ratio 0.0450.0810.0580.1820.2260.2080.2010.1860.1910.270.2580.31
EPS 0.230.430.310.850.910.790.880.690.660.550.42.71
EPS Diluted 0.220.420.310.850.910.790.880.690.660.550.42.71
EBITDA 50.83666.48171.389111.256111.56999.60387.74673.79467.35342.87832.57730.987
EBITDA Ratio 0.1080.1340.1410.2530.2970.280.2860.2830.2790.3010.3030.353